Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285061 · ClinicalTrials.gov registry record · NA
Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT03285061 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 75 participants.
The verdict
NCT03285061, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at medication drop off locations.
Interventions
- DEVICE Deterra Drug Deactivation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03285061
The ClinicalTrials.gov registry entry for NCT03285061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deterra Drug Deactivation System is the first listed.
NCT03285061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03285061 about?
NCT03285061 is a clinical study titled "Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery". This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at me...
What is the current status of trial NCT03285061?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-10-01. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT03285061?
The interventions under investigation include: Deterra Drug Deactivation System (DEVICE).
Who is sponsoring clinical trial NCT03285061?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.